# Terence T. Sio, M.D., M.S. – FDA 483, Mar 23, 2026

Source: https://www.keypedia.com/records/483/terence-t-sio-md-ms/49d49755-2bfd-480f-a421-8d80bba10afc

> FDA 483 for Terence T. Sio, M.D., M.S. on March 23, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Terence T. Sio, M.D., M.S.
- Inspection Date: 2026-03-23
- Product Type: other
- Office Name: Denver District Office
- Summary: An FDA inspection of Terence T. Sio, M.D., M.S., a clinical investigator in Phoenix, AZ, revealed one observation related to the conduct of a clinical study. The primary concern was the late reporting of Serious Adverse Events (SAEs) to the study sponsor, indicating a failure to follow the investigational plan. This suggests a moderate compliance issue in clinical trial oversight.

## Related Officers

- [Korina Serrano](https://www.keypedia.com/people/korina-serrano/c96035ff-7eb6-4049-ab6f-248c3c959c3b)

Company: https://www.keypedia.com/companies/terence-t-sio-md-ms/e80ce9d0-9971-4755-a8f0-d1d701912016

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face